Osteopontin (OPN) is a multifunctional glycoprotein that physiologically interacts with different types of integrins. It is considered to be a possible prognostic biomarker in certain tumor types; how
Transcriptomic profiling of Ras/Src tumours from animals raised on CD versus HSD enabled the identification of (i) candidate tumour-derived factors which may impact muscle-wasting and (ii) candidate a
KPC46 orthotopic tumors were treated with a combination of Irreversible electroporation and intratumoral agonistic CD40 Ab injection and RNA-seq was performed on the primary tumor site.
